CREDENCE: A silver lining in the dark cloud of diabetic nephropathy

[...]SGLT2 inhibitors have a strong effect in reducing the risk of deteriorating heart failure, which is closely associated with advanced diabetic nephropathy. A recent study of patients with heart failure and a reduced ejection fraction showed that the risk of deteriorating heart failure or death f...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of diabetes investigation Ročník 11; číslo 3; s. 527 - 529
Hlavní autoři:	Hanai, Ko, Babazono, Tetsuya
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Japan John Wiley & Sons, Inc 01.05.2020 John Wiley and Sons Inc Wiley
Témata:	Antidiabetics Blood pressure Canagliflozin - therapeutic use Cardiovascular disease Clinical trials Commentaries Confidence intervals Congestive heart failure Diabetes Diabetes mellitus Diabetic Nephropathies - diagnosis Diabetic Nephropathies - drug therapy Diabetic Nephropathies - epidemiology Diabetic nephropathy Enzymes Glucose Heart failure Humans Kidney diseases Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - prevention & control Nephropathy Peptides Randomized Controlled Trials as Topic - methods Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
ISSN:	2040-1116, 2040-1124, 2040-1124
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!